Breaking News

Champalimaud Installs Lonza’s MODA-ES Platform

Aims to improve and streamline the cell therapy manufacturing process to improve accessibility for cancer therapies.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Champalimaud Foundation, a biomedical clinical research organization, has installed Lonza’s MODA-ES Platform at the Champalimaud Clinical Centre in Lisbon, Portugal.   Through the installation of MODA-ES, the Champalimaud Foundation aims to improve and streamline the cell therapy manufacturing process to improve accessibility for cancer therapies.   In collaboration with academic and industry partners, the Champalimaud Foundation has built a state-of-the-art multipurpose GMP facility to deve...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters